Press Room

Press Room

Press release

Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women.

Read more >
Press release

Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec

Read more >
Press release

The CEO of Duchesnay Pharmaceutical Groupe, Éric Gervais, shared his thoughts on the future of the life sciences industry with Investment Reports.

Read more >